Clinical Data Completes Acquisition Of Icoria, Inc. (Formerly Paradigm Genetics)
Published: Dec 21, 2005
NEWTON, Mass.--(BUSINESS WIRE)--Dec. 20, 2005--Clinical Data, Inc. (NASDAQ:CLDA) today announced that it has closed its previously announced acquisition of Icoria, Inc. following the approval of the merger by the stockholders of Icoria. The terms of the Agreement and Plan of Merger include the exchange of each outstanding share of Icoria common stock for 0.01552 shares of Clinical Data common stock. Effective immediately, Icoria will cease trading on the OTC Bulletin Board under ticker symbol ICOR.OB. In conjunction with the acquisition, G. Steven Burrill will join Clinical Data's board of directors effective immediately, bringing the total number of directors to eight. Mr. Burrill was Chairman of Icoria's board.